The Drug Enforcement Administration took steps today against synthetic stimulants and cannabinoids
So if that little froggie pictured above used synthetics to get the sly semi-smile look some drug users get when they finally figure out the world (only to eventually forget what it was that had occurred to them), he's in hot water. And you know how it goes for frogs in hot water, more or less.
You want the formal, boring technical language of what got acted on today? Okay, you got it:
Today the United States Drug Enforcement Administration (DEA) published a Final Rule to permanently control 3,4-methylenedioxy-N-methylcathinone (methylone) and a Notice of Intent to temporarily schedule three synthetic cannabinoids....(UR-144, XLR11, and AKB48)
The cannabinoids are used in "herbal incense." The methylone is used in bath salts for its psychoactive effects, the DEA says.
The methylone got slammed hardest:
The first of two notices published in the Federal Register this morning is a Final Rule permanently placing methylone, a synthetic stimulant drug that has been encountered in falsely marketed "bath salt" products, into Schedule I under the Controlled Substances Act, the most restrictive category that is reserved for unsafe, highly abused substances with no accepted medical use.
Methylone is abused by individuals for its psychoactive effects, and this abuse has had an adverse effect on public health and safety, including death.
Today's action against methylone is the final step in a process that began in October 2011.
Here's what the DEA has to say about the synthetics:
Over the past two years, synthetic stimulants sold under the guise of "bath salts" or "plant food" has become increasingly popular, particularly among teens and young adults, and is sold at a variety of retail outlets and over the Internet.
However, they have not been approved by the FDA for human consumption or for medical use. Marketed under names such as "Ivory Wave", "Purple Wave", "Vanilla Sky" or "Bliss," these products are comprised of substances perceived as mimics of cocaine, LSD, MDMA, and/or methamphetamine.
Users have reported impaired perception, reduced motor control, disorientation, extreme paranoia, and violent episodes. The long-term physical and psychological effects of these substances and their associated products are unknown but potentially severe.
The DEA noted that the synthetic cannabinoids mimic the THC found in weed. "The long-term physical and psychological effects of these substances and their associated products are unknown but potentially severe," the DEA said.
Here's what the agency says about its action against the drug:
The second Federal Register Notice published today is a Notice of Intent to temporarily control three synthetic cannabinoids (UR-144, XLR11, and AKB48) often seen in falsely marketed "herbal incense" products. DEA has taken action upon finding these three substances pose an imminent hazard to public safety. This action will become effective upon publishing a Final Order to temporarily control these substances as Schedule I substances for up to two years, with the possibility of a one-year extension.